83 results
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
distinguished clinicians and scientists with expertise in the development of innovative therapies for brain cancer. The Global Coalition for Adaptive … of improving patients’ lives by developing innovative therapies and treatment solutions. “We’ve not focused enough resources and effort on the paediatric
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
15 Dec 22
Kazia Launches Preclinical Collaboration with Qimr Berghofer Medical Research Institute and Announces Patent Filing
7:45am
to explore innovative approaches to cancer treatment.
The collaboration is ongoing and will build on initial research that has already led
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
15 Sep 22
Current report (foreign)
9:12am
- Develop value Partner for Dec 2018 – Tesaro acquired by GSK valued assets through late-stage from larger innovative clinical development and $360 $5.1
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
1 Sep 22
Current report (foreign)
4:07pm
and immuno-oncology. His main research interests are early clinical development, phase I trials across solid tumours, innovative methods of evaluation
6-K
cr1n 14bq6l
12 Nov 21
Current report (foreign)
6:13am
6-K
amt42 d3n
5 Nov 21
Current report (foreign)
6:17am
6-K
k1lxw mpj1rq6ed
19 Apr 21
Current report (foreign)
6:17am
6-K
0idnbpy0n 2pzz3g1a3
18 Mar 21
Current report (foreign)
6:03am
6-K
tqoqqcr2hqn4gxmq8v
1 Mar 21
Current report (foreign)
6:06am
6-K
zusm5b
29 Jan 21
Current report (foreign)
6:08am
6-K
uccgr
7 Jan 21
Current report (foreign)
6:09am
6-K
hmwydt4jkcs3c ic
14 Dec 20
Current report (foreign)
6:09am
6-K
arh5kc jqkqhenxn
10 Dec 20
Current report (foreign)
6:05am
6-K
5oks1g9e
9 Dec 20
Current report (foreign)
6:06am
6-K
c9r5uc
18 Nov 20
Current report (foreign)
6:06am
6-K
gui3m1s7 x1t3k1
6 Nov 20
Current report (foreign)
6:07am
6-K
q5n9grf
6 Nov 20
Current report (foreign)
6:04am
6-K
nl6vfhlw5fqah 8bri
30 Oct 20
Current report (foreign)
6:06am